Sanofi (EPA:SAN)
France
· Delayed Price · Currency is EUR 76.39
-1.34 (-1.72%)
Mar 6, 2026, 5:35 PM CET
Sanofi Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 43,626 | 41,081 | 37,817 | 37,651 | 37,761 | Upgrade
|
| Other Revenue | 3,090 | 3,205 | 3,292 | 2,653 | 1,414 | Upgrade
|
| Revenue | 46,716 | 44,286 | 41,109 | 40,304 | 39,175 | Upgrade
|
| Revenue Growth (YoY) | 5.49% | 7.73% | 2.00% | 2.88% | 4.83% | Upgrade
|
| Cost of Revenue | 12,923 | 13,195 | 12,619 | 11,869 | 12,251 | Upgrade
|
| Gross Profit | 33,793 | 31,091 | 28,490 | 28,435 | 26,924 | Upgrade
|
| Selling, General & Admin | 9,616 | 9,247 | 9,003 | 8,785 | 9,599 | Upgrade
|
| Research & Development | 7,842 | 7,394 | 6,507 | 6,501 | 5,692 | Upgrade
|
| Amortization of Goodwill & Intangibles | 1,776 | 1,749 | 1,911 | 1,578 | 1,580 | Upgrade
|
| Other Operating Expenses | 4,909 | 3,832 | 2,948 | 1,190 | 1,488 | Upgrade
|
| Operating Expenses | 24,143 | 22,222 | 20,369 | 18,054 | 18,359 | Upgrade
|
| Operating Income | 9,650 | 8,869 | 8,121 | 10,381 | 8,565 | Upgrade
|
| Interest Expense | -531 | -641 | -589 | -402 | -362 | Upgrade
|
| Interest & Investment Income | 320 | 413 | 527 | 239 | 3 | Upgrade
|
| Earnings From Equity Investments | -155 | 60 | -136 | 55 | 39 | Upgrade
|
| Currency Exchange Gain (Loss) | 2 | 6 | -2 | -3 | 2 | Upgrade
|
| Other Non Operating Income (Expenses) | 122 | -268 | -574 | -14 | 70 | Upgrade
|
| EBT Excluding Unusual Items | 9,408 | 8,439 | 7,347 | 10,256 | 8,317 | Upgrade
|
| Merger & Restructuring Charges | -1,264 | -1,406 | -1,039 | -1,090 | -824 | Upgrade
|
| Gain (Loss) on Sale of Investments | -9 | - | -1 | 1 | 3 | Upgrade
|
| Gain (Loss) on Sale of Assets | 485 | 539 | 484 | 481 | 418 | Upgrade
|
| Asset Writedown | -2,241 | -248 | -896 | 203 | -192 | Upgrade
|
| Legal Settlements | -255 | -470 | -196 | -143 | - | Upgrade
|
| Other Unusual Items | -104 | -96 | 416 | 284 | 115 | Upgrade
|
| Pretax Income | 6,020 | 6,758 | 6,115 | 9,992 | 7,837 | Upgrade
|
| Income Tax Expense | 1,043 | 1,204 | 1,017 | 1,909 | 1,558 | Upgrade
|
| Earnings From Continuing Operations | 4,977 | 5,554 | 5,098 | 8,083 | 6,279 | Upgrade
|
| Earnings From Discontinued Operations | 2,874 | 64 | 338 | 401 | - | Upgrade
|
| Net Income to Company | 7,851 | 5,618 | 5,436 | 8,484 | 6,279 | Upgrade
|
| Minority Interest in Earnings | -38 | -58 | -36 | -113 | -56 | Upgrade
|
| Net Income | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 | Upgrade
|
| Net Income to Common | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 | Upgrade
|
| Net Income Growth | 40.52% | 2.96% | -35.49% | 34.52% | -49.38% | Upgrade
|
| Shares Outstanding (Basic) | 1,220 | 1,251 | 1,252 | 1,252 | 1,253 | Upgrade
|
| Shares Outstanding (Diluted) | 1,226 | 1,256 | 1,256 | 1,257 | 1,258 | Upgrade
|
| Shares Change (YoY) | -2.43% | -0.02% | -0.04% | -0.08% | -0.18% | Upgrade
|
| EPS (Basic) | 6.40 | 4.44 | 4.31 | 6.69 | 4.97 | Upgrade
|
| EPS (Diluted) | 6.37 | 4.44 | 4.31 | 6.67 | 4.95 | Upgrade
|
| EPS Growth | 43.55% | 2.94% | -35.31% | 34.73% | -49.28% | Upgrade
|
| Free Cash Flow | 8,988 | 7,348 | 8,639 | 8,997 | 9,044 | Upgrade
|
| Free Cash Flow Per Share | 7.33 | 5.85 | 6.88 | 7.16 | 7.19 | Upgrade
|
| Dividend Per Share | 4.120 | 3.920 | 3.760 | 3.560 | 3.330 | Upgrade
|
| Dividend Growth | 5.10% | 4.25% | 5.62% | 6.91% | 4.06% | Upgrade
|
| Gross Margin | 72.34% | 70.20% | 69.30% | 70.55% | 68.73% | Upgrade
|
| Operating Margin | 20.66% | 20.03% | 19.75% | 25.76% | 21.86% | Upgrade
|
| Profit Margin | 16.72% | 12.55% | 13.14% | 20.77% | 15.88% | Upgrade
|
| Free Cash Flow Margin | 19.24% | 16.59% | 21.02% | 22.32% | 23.09% | Upgrade
|
| EBITDA | 12,638 | 11,665 | 11,076 | 13,093 | 11,251 | Upgrade
|
| EBITDA Margin | 27.05% | 26.34% | 26.94% | 32.49% | 28.72% | Upgrade
|
| D&A For EBITDA | 2,988 | 2,796 | 2,955 | 2,712 | 2,686 | Upgrade
|
| EBIT | 9,650 | 8,869 | 8,121 | 10,381 | 8,565 | Upgrade
|
| EBIT Margin | 20.66% | 20.03% | 19.75% | 25.76% | 21.86% | Upgrade
|
| Effective Tax Rate | 17.33% | 17.82% | 16.63% | 19.11% | 19.88% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.